Post by Paras Magdum
Recently completed B.pharmacy and willing to work in Quality Control, Hospital management, P.V and clinical data management, clinical trials. willing to give my best and eager to learn something new
š Global Pharma & Biotech Weekly Highlights The pharmaceutical and life sciences sector continues to evolve rapidly through major acquisitions, strategic collaborations, regulatory changes, AI innovation, and supply chain transformation. š¹ Major Deals & Partnerships ā¢ Merck KGaA announced its $11.3 billion acquisition of Bio-Techne, strengthening its multi-omics and spatial biology capabilities. ā¢ GSK launched a $10.6 billion bid for oncology innovator Nuvalent, reinforcing its commitment to precision cancer therapies. ā¢ Novartis partnered with Antares Therapeutics in a collaboration worth up to $1.9 billion to discover small molecules targeting previously "undruggable" oncology pathways. š¹ Regulatory & Legal Updates ā¢ The United States is considering trade investigations into European pharmaceutical pricing policies, potentially impacting future market dynamics and import costs. ā¢ Pfizer secured dismissal from a long-running generic drug antitrust lawsuit involving alleged price-fixing activities. ā¢ Bayer received a favorable U.S. Supreme Court ruling limiting future Roundup-related warning lawsuits. š¹ Approvals & Technology ā¢ The FDA expanded the indication for Ibrance, broadening treatment options for advanced breast cancer patients. ā¢ Eli Lilly and Nvidia announced a landmark $1 billion AI partnership aimed at accelerating drug discovery using next-generation supercomputing infrastructure. š¹ Supply Chain Transformation ā¢ The global "China Plus One" strategy continues to reshape pharmaceutical manufacturing. ā¢ Indian CDMOs, including Sai Life Sciences, are rapidly expanding capacities as global companies diversify supply chains and increase investments in India. š Industry Outlook The industry is witnessing a powerful convergence of biotechnology, artificial intelligence, precision medicine, and supply chain diversification. Companies investing in innovation, strategic partnerships, and advanced manufacturing capabilities are positioning themselves for the next era of healthcare transformation. #Pharma #Biotech #LifeSciences #MergersAndAcquisitions #DrugDiscovery #ArtificialIntelligence #Oncology #PrecisionMedicine #CDMO #SupplyChain #ClinicalResearch #PharmaceuticalIndustry #HealthcareInnovation #MakeInIndia #DigitalHealth
